StonvexLoading…
StonvexStonvexStonvexCore line items from LAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $9.69B | $9.27B | $37.63B | $28.44B | $18.76B |
Operating Income | Not available | $335.80M | $1.59B | $1.25B | $831.60M |
Net Income | Not available | $100.40M | $819.60M | $682.70M | $465.60M |
EPS (Diluted) | $8.85 | $4.28 | $32.32 | $26.42 | $17.80 |
Total Assets | Not available | $25.75B | $25.11B | $24.52B | $24.16B |
Total Liabilities | Not available | $19.34B | $18.48B | $17.73B | $17.15B |
Cash & Equivalents | Not available | $160.80M | $391.30M | $206.50M | $202.80M |
Free Cash Flow OCF − CapEx | Not available | $-205.50M | $5.80M | $-24.70M | $182.60M |
Shares Outstanding | Not available | 22.80M | 23.50M | 24.40M | 25.70M |